We are live on
!
Find out more
NFC
Northeast Financial Consultants Portfolio holdings
AUM
$2.45B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.17%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$301M
AUM Growth
+$27.9M
(+10%)
Cap. Flow
+$15.1M
Cap. Flow
% of AUM
5%
Top 10 Holdings %
Top 10 Hldgs %
52.22%
Holding
163
New
13
Increased
61
Reduced
24
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Financials ETF
VFH
|
+$2.61M |
| 2 |
Vanguard Morningstar Growth ETF
VUG
|
+$2.3M |
| 3 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.21M |
| 4 |
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
|
+$1.18M |
| 5 |
Home Depot
HD
|
+$1.16M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$766K |
| 2 |
CVS Health
CVS
|
+$638K |
| 3 |
GE Aerospace
GE
|
+$472K |
| 4 |
Merck
MRK
|
+$442K |
| 5 |
KMI.PRA
Kinder Morgan, Inc.
KMI.PRA
|
+$426K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Energy | 6.73% |
| 3 | Communication Services | 4.72% |
| 4 | Financials | 4.26% |
| 5 | Technology | 4.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
BioCryst Pharmaceuticals
BCRX
$2.4B
| $98K | 0.03% |
20,000
| – | – |
|
|
IRD
152
Opus Genetics
IRD
$302M
| $30K | 0.01% |
313
| – | – |
|
153
Vanguard Total Bond Market
BND
$161B
| – | – |
-2,591
| Closed | -$212K |
|
|
154
CVS Health
CVS
$122B
| – | – |
-7,849
| Closed | -$638K |
|
|
155
GE Aerospace
GE
$384B
| – | – |
-4,076
| Closed | -$472K |
|
156
iShares International Select Dividend ETF
IDV
$8.57B
| – | – |
-7,310
| Closed | -$247K |
|
157
Illinois Tool Works
ITW
$84.5B
| – | – |
-2,000
| Closed | -$296K |
|
158
Omnicell
OMCL
$1.68B
| – | – |
-4,000
| Closed | -$204K |
|
|
WBA
159
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-3,693
| Closed | -$285K |
|
|
ISBC
160
DELISTED
Investors Bancorp, Inc.
ISBC
| – | – |
-20,400
| Closed | -$278K |
|
|
KMI.PRA
161
DELISTED
Kinder Morgan, Inc.
KMI.PRA
| – | – |
-10,000
| Closed | -$426K |
|
|
TERP
162
DELISTED
TerraForm Power, Inc
TERP
| – | – |
-10,000
| Closed | -$132K |
|
Similar funds
MC
WBA
MD
GL
SVCF
GLA
HIP
MME
Northeast Financial Consultants's Q4 2017 Portfolio in Review
As of Q4 2017, Northeast Financial Consultants held 163 positions worth $301M, up 10% from $273M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Northeast Financial Consultants deployed $15.1M of net new capital in Q4 2017, opening 13 new positions and adding to 61 existing holdings. Its largest new stake was Home Depot: 6,747 shares worth $1.28M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Energy and Communication Services.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $766K trimmed.
- Northeast Financial Consultants's largest Q4 2017 buy was Home Depot: 6,747 shares worth $1.28M.
- Northeast Financial Consultants added most to Vanguard Financials ETF in Q4 2017, an estimated $2.61M increase.
- Northeast Financial Consultants's biggest Q4 2017 reduction was Thermo Fisher Scientific, cutting an estimated $766K.
- Northeast Financial Consultants fully exited CVS Health in Q4 2017, selling an estimated $638K.
- Northeast Financial Consultants's ten largest holdings make up 52% of its $301M portfolio in Q4 2017.
- Northeast Financial Consultants opened 13 new positions and closed 10 in Q4 2017.
- Northeast Financial Consultants's portfolio value rose 10% quarter-over-quarter to $301M.
Based on Northeast Financial Consultants's 13F filing for Q4 2017, filed 14 Feb 2018.